Ubs Group Ag Bone Biologics Corp Transaction History

Ubs Group Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.21 - $0.39 $5,961 - $11,072	28,390 Added 186.01%	43,653 $11,000
Q4 2022 Feb 08, 2023	BUY	$0.19 - $32.7 $2,899 - $499,100	15,263 New	15,263 $3,000
Q2 2022 Aug 10, 2022	BUY	$0.14 - $0.41 $1,062 - $3,111	7,588 Added 8927.06%	7,673 $11,000
Q1 2022 May 16, 2022	BUY	$0.23 - $0.77 $19 - $65	85 New	85 $0

Ticker BBLG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,128,400
Market Cap $24.4M
Description
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for sp...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.